USARx offers multiple ways to purchase this medication. Choose the Best option for you!
Yes100% of Medicare Part D and Medicare Advantage plans cover this drug.
It depends. Which coverage stage are you in? Click on a tab below…
$1 – $54
In the Deductible co-pay stage, you are responsible for the full cost of your prescriptions. Your Medicare deductible cannot exceed $360 in 2016.
Here are some ways that may lower the cost of your metronidazole prescription.
If your Medicare co-pay is higher, you can save money by using a USARx coupon instead.
Applies to metronidazole: oral capsule, oral powder for suspension, oral tablet
Other dosage forms:
Oral route (Tablet; Tablet, Extended Release; Capsule)
Metronidazole has been shown to be carcinogenic in mice and rats. Unnecessary use of the drug should be avoided. Its use should be reserved only for conditions for which it is approved.
Along with its needed effects, metronidazole may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking metronidazole:
Incidence not known
Some side effects of metronidazole may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
Applies to metronidazole: compounding powder, intravenous powder for injection, intravenous solution, oral capsule, oral suspension, oral tablet, oral tablet extended release
The most serious side effects reported were convulsive seizures, encephalopathy, aseptic meningitis, optic neuropathy, and peripheral neuropathy (characterized by numbness/paresthesia of an extremity).
Very common (10% or more): Headache (up to 18%)
Common (1% to 10%): Dysgeusia/taste perversion (e.g., metallic taste, sharp unpleasant metallic taste, taste of alcoholic beverages modified), dizziness
Rare (0.01% to 0.1%): Encephalopathy (e.g., confusion, fever, headache, hallucinations, paralysis, light sensitivity, disturbances in sight and movement, stiff neck), aseptic meningitis, seizure, somnolence, peripheral neuropathy, ataxia
Very rare (less than 0.01%): Subacute cerebellar syndrome (e.g., ataxia, dysarthria, gait impaired, nystagmus, tremor), drowsiness, convulsions, incoordination
Frequency not reported: Dysarthria, hypoesthesia, paresthesia, peripheral sensory neuropathy, transient epileptiform seizures, hearing impaired/hearing loss (including sensorineural), tinnitus, taste disorders/unpleasant taste in mouth, nystagmus, convulsive seizure, numbness, syncope, vertigo, paralysis
Very common (10% or more): Nausea (up to 10%)
Common (1% to 10%): Abdominal pain, diarrhea, dry mouth, stomatitis, glossitis
Rare (0.01% to 0.1%): Pancreatitis, upper abdominal pain/epigastralgia, vomiting
Frequency not reported: Constipation, tongue discoloration, oral mucositis, furry/furred tongue, gastrointestinal disturbances (e.g., epigastric pain/distress), proctitis, sudden overgrowth of Candida in mouth, abdominal cramping, dyspepsia, pseudomembranous colitis, mucositis
Very common (10% or more): Vaginitis (up to 15%)
Common (1% to 10%): Genital pruritus, abnormal urine, dysmenorrhea, moniliasis, urinary tract infection
Rare (0.01% to 0.1%): Chromaturia
Very rare (less than 0.01%): Darkened urine
Frequency not reported: Vaginal dryness, vulva dryness, dysuria, vaginal candidiasis, dyspareunia, polyuria, incontinence, cystitis, pyuria, proliferation of Candida in vagina
Common (1% to 10%): Bacterial infection, influenza-like symptoms
Uncommon (0.1% to 1%): Asthenia
Rare (0.01% to 0.1%): Mucosal inflammation, pyrexia/fever
Very rare (less than 0.01%): Flushing
Frequency not reported: Malaise, face edema, peripheral edema, chest pain, chills, overgrowth of Candida, disulfiram-like reaction, weakness, sensation of pelvic pressure
Common (1% to 10%): Upper respiratory tract infection, rhinitis, sinusitis, pharyngitis
Frequency not reported: Dyspnea, nasal congestion, hiccup
Common (1% to 10%): Myalgia
Very rare (less than 0.01%): Arthralgia
Frequency not reported: Muscle spasms, fleeting joint pain, stiff neck
Uncommon (0.1% to 1%): Leukopenia
Rare (0.01% to 0.1%): Neutropenia, thrombocytopenia, pancytopenia, agranulocytosis
Frequency not reported: Eosinophilia, bone marrow aplasia, bone marrow depression, blood dyscrasia
Rare (0.01% to 0.1%): Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, erythema multiforme
Very rare (less than 0.01%): Skin rash, pustular eruptions, acute generalized exanthematous pustulosis, pruritus
Frequency not reported: Fixed drug eruption, swelling face, urticaria, hyperhidrosis, erythema, drug reaction with eosinophilia and systemic symptoms (DRESS), erythematosus rash, mild erythematous eruptions, pustulosis
Rare (0.01% to 0.1%): Cholestatic hepatitis
Very rare (less than 0.01%): Increased liver enzymes (AST, ALT, alkaline phosphatase), cholestatic/mixed hepatitis, hepatocellular liver injury, jaundice, liver failure requiring liver transplant, abnormal liver function tests
Frequency not reported: Increased liver enzyme, hepatotoxicity/liver failure in patients with Cockayne syndrome, drug-induced hepatitis
Rare (0.01% to 0.1%): Anaphylaxis, anaphylactic shock, Jarisch-Herxheimer reaction
Frequency not reported: Serum sickness-like reaction, immediate/delayed hypersensitivity reactions, anaphylactic reaction, hypersensitivity
Rare (0.01% to 0.1%): Hallucinations
Very rare (less than 0.01%): Confusion/confusional state, psychotic disorders
Frequency not reported: Depression, insomnia, depressed mood, decreased libido, irritability, psychosis, disorientation, psychotic reaction
Rare (0.01% to 0.1%): Optic neuropathy, diplopia, myopia
Very rare (less than 0.01%): Vision disorders (e.g., diplopia, myopia)
Frequency not reported: Optic neuropathy/neuritis, saccadic eye movement, blurred vision, decreased visual acuity, changed color vision, light sensitivity
Frequency not reported: Flattening of T-wave on ECG, tachycardia, palpitations, QT interval prolonged on ECG
Frequency not reported: Anorexia, decreased appetite
An increased incidence of gastrointestinal and certain extraintestinal cancers have been reported in patients with Crohn's disease. Breast and colon cancer have been reported in medical literature in Crohn's disease patient treated with high doses of this drug for a prolonged duration; causality was not established.
Frequency not reported: Breast cancer, colon cancer, gastrointestinal cancer, certain extraintestinal cancers
Frequency not reported: Injection site reaction, thrombophlebitis
June 25, 2020
June 23, 2020
June 22, 2020
June 18, 2020
June 17, 2020
June 4, 2020